Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Interventional × Xeroderma Pigmentosum × afamelanotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Xeroderma Pigmentosum 2 Keratosis, Actinic 1 Carcinoma, Squamous Cell 1

Interventions

afamelanotide 2 Specimen Handling 1 Nivolumab 1 Ipilimumab 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05370235 2023-09-21

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

Clinuvel Pharmaceuticals Limited

Phase 2 Unknown

Xeroderma Pigmentosum

NCT05159752 2023-06-18

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

Clinuvel Pharmaceuticals Limited

Phase 2 Unknown

Xeroderma Pigmentosum

Data powered by HemOnc (CC BY 4.0) Colophon ⚡